Targeting Cancer Fitness Gene Metadherin in Metastatic Breast Cancer

9:30 AM Eastern Time (8:30CT, 7:30 MT, 6:30 PT), Thur. March 3, 2022

9:30-10:00 AM Prerecorded lecture (available to registrants for 30 days since the lecture).

10:00-10:30 AM Q&A, and interview about career development and scientific discoveries.

Venue: Join Zoom Meeting https://rutgers.zoom.us/j/8499671480?pwd=NktWN3BqWWNuZXBtMzk5Y3ZIWnJHUT09

Meeting ID: 849 967 1480
Password: 6096833

Yibin Kang, PhD, is the Warner-Lambert Parke-Davis Professor of Molecular Biology at Princeton University, NJ. His research focuses on metastasis, the major cause of death from cancer. Specifically, Kang is investigating the molecular mechanisms of breast cancer metastasis. His research is supported by grants from a myriad of federal and private sources, and he has published more than 120 original articles in leading scientific journals.

Moderator: Yuan Li, MD, PhD, Shanghai Cancer Center, Fudan University.

Penn Medicine Princeton Health is accredited by the Medical Society of New Jersey to provide continuing medical education for physicians. Penn Medicine Princeton Health designates this live activity for a maximum of one (1) AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
If you have a disability that may require special assistance, please contact Janis Puleio, CME Coordinator at (609) 853-7450.

Sponsor: 91360.AI, LLC and Princeton Medical Center; Non-financial sponsor: TJMCOAA

Princeton Biomedical Seminars